Integra LifeSciences Correlations
| IART Stock | USD 22.01 0.19 0.87% |
The current 90-days correlation between Integra LifeSciences and ICU Medical is 0.15 (i.e., Average diversification). The correlation of Integra LifeSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Integra LifeSciences Correlation With Market
Weak diversification
The correlation between Integra LifeSciences Holdings and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Integra LifeSciences Holdings and DJI in the same portfolio, assuming nothing else is changed.
Integra |
Moving together with Integra Stock
Moving against Integra Stock
| 0.45 | OCX | OncoCyte Corp | PairCorr |
| 0.33 | MNDR | Mobile health Network | PairCorr |
| 0.49 | INBX | Inhibrx Symbol Change | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Integra Stock performing well and Integra LifeSciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Integra LifeSciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ICUI | 1.72 | (0.04) | 0.00 | (0.06) | 0.00 | 3.10 | 11.84 | |||
| CNMD | 1.69 | (0.18) | 0.00 | 4.27 | 0.00 | 3.52 | 13.79 | |||
| HAE | 1.76 | (0.23) | 0.00 | (0.37) | 0.00 | 3.37 | 15.77 | |||
| NUVA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MMSI | 1.19 | 0.14 | 0.10 | 0.10 | 1.28 | 2.95 | 7.42 |
Integra LifeSciences Corporate Executives
Elected by the shareholders, the Integra LifeSciences' board of directors comprises two types of representatives: Integra LifeSciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Integra. The board's role is to monitor Integra LifeSciences' management team and ensure that shareholders' interests are well served. Integra LifeSciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Integra LifeSciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lea Knight | Executive CFO | Profile |